Elk Creek Partners’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-208,724
Closed -$10.1M 161
2017
Q2
$10.1M Sell
208,724
-28,575
-12% -$1.68M 0.66% 57
2017
Q1
$17.2M Sell
237,299
-42,847
-15% -$2.83M 1.05% 31
2016
Q4
$16M Buy
280,146
+61,918
+28% +$5.67M 1.08% 31
2016
Q3
$27.9M Buy
218,228
+69,939
+47% +$8.95M 1.84% 7
2016
Q2
$18.5M Buy
148,289
+19,046
+15% +$2.19M 1.32% 19
2016
Q1
$10.8M Buy
129,243
+15,312
+13% +$1.26M 0.8% 50
2015
Q4
$11.3M Buy
113,931
+64,457
+130% +$6.91M 0.8% 46
2015
Q3
$6.07M Buy
+49,474
New +$6.72M 0.49% 79
2014
Q3
Sell
-24,480
Closed -$3.72M 110
2014
Q2
$3.72M Buy
24,480
+9,465
+63% +$1.26M 1.01% 42
2014
Q1
$1.93M Buy
15,015
+3,731
+33% +$580K 0.83% 64
2013
Q4
$1.97M Buy
+11,284
New +$1.94M 1.42% 12

Other funds holding ELGX

Elk Creek Partners's ELGX Position: Q3 2017 in Review

Elk Creek Partners sold out of Endologix Inc (ELGX) in Q3 2017, closing a stake of 208,724 shares — an estimated $10.1M sold.

Elk Creek Partners first reported a position in ELGX in Q4 2013 and held it in 11 quarters. The position peaked at $27.9M in Q3 2016. 106 funds tracked by Wall St. Rank hold ELGX as of Q3 2017.

  • Elk Creek Partners reported no remaining Endologix Inc position as of Q3 2017 after selling out during the quarter.
  • Elk Creek Partners sold 208,724 Endologix Inc shares in Q3 2017, an estimated $10.1M.
  • Elk Creek Partners first reported a position in Endologix Inc in Q4 2013 and held it in 11 quarters.
  • Elk Creek Partners's Endologix Inc position peaked at $27.9M in Q3 2016.
  • 106 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2017.

Based on Elk Creek Partners's 13F filing for Q3 2017, filed 13 Nov 2017.